News Daily News Prevention Must Be Prioritized in Heart Failure Care: HFSA/ASPC Yael L. Maxwell August 18, 2025
News Daily News Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data L.A. McKeown July 24, 2025
News Daily News AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review Todd Neale July 24, 2025
News Daily News FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF Caitlin E. Cox July 14, 2025
News Daily News Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study Todd Neale May 09, 2025
News Daily News Sotagliflozin Reduces Ischemic Risk in SCORED Analysis Yael L. Maxwell February 25, 2025
News Daily News Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3 Yael L. Maxwell January 15, 2025
News Daily News FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity L.A. McKeown December 13, 2024
News Daily News CMS Announces Negotiated Medicare Prices for First 10 Drugs Yael L. Maxwell August 16, 2024
News Daily News Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors Yael L. Maxwell August 15, 2024
News Daily News FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF L.A. McKeown August 05, 2024
News Daily News Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF Michael O'Riordan July 26, 2024
News Daily News Semaglutide Has Similar Benefits in Women and Men With HFpEF Todd Neale June 26, 2024
News Daily News Kidney Events High in Older Patients After HF Hospitalization L.A. McKeown May 30, 2024
News Daily News SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER Michael O'Riordan May 07, 2024
News Daily News Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All Michael O'Riordan September 18, 2023
News Daily News Congestion Biomarker CA125 Signals Worse Outcomes in Ambulatory HFrEF Todd Neale July 03, 2023